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Summary Studies have reported that Candida glabrata infections are more common in older adults.
We sought to determine colonisation rates of C. glabrata in the oral cavity and its
relationship with age, comorbid illnesses and hospital or extended care facility stay.
Samples were obtained from four sites in the oral cavity and from dentures, when
available, from 408 subjects from the community (136), hospital (126) or an extended
care facility (146). Overall, 219 (53.7%) subjects were colonised with yeast; the
predominant species was Candida albicans. Sixty-two patients (15.2%) were colonised
with C. glabrata. None of the subjects <40 years was colonised with C. glabrata; in those
from the community, only nine persons, all of whom were >60 years, were colonised
with C. glabrata. By multivariate analysis, increasing age, dentures and use of
psychotropic medications were independently associated with C. glabrata colonisation;
residing in the community, rather than hospital or extended care, was strongly
protective against colonisation. Candida glabrata colonisation is multifactorial; age, and
hospitalisation ⁄ extended care stay contribute to colonisation. Dentures are strongly
associated with colonisation with any yeast and with C. glabrata. Further study is
needed to evaluate the relationship of these findings to increasing C. glabrata infections
in older adults.
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Introduction
Candida species are an increasingly common cause of
bloodstream infections in hospitalised patients. In
some institutions, a shift in the species of Candida
causing fungaemia has occurred with Candida glabrata
being the most common non-albicans Candida species
nowadays.1–5 As many as one quarter to one-third of all
cases of fungaemia in some medical centres are caused
by this species that is intrinsically more resistant to
commonly used triazole agents.
The increase in the incidence of C. glabrata fungaemia
appears to be multifactorial, and include increased use
of fluconazole, especially in haematology and stem cell
transplant units, and geographical differences.2,4,5 Sev-
eral studies have reported that C. glabrata infections are
more common in older adults than in younger individ-
uals2,6,7 and are uncommonly found in neonates and
young children.3,6
The association between C. glabrata fungaemia and
older age is poorly understood. One study that enrolled a
small number of subjects found higher rates of C.
glabrata oropharyngeal colonisation in adults over
80 years of age,8 but others have found no oropharyn-
geal colonisation with C. glabrata in older adults.9 A
prior study from our institution noted that C. glabrata
was a common coloniser among older residents of an
extended care facility.10 We sought to extend these
observations to a large sample of adults of various ages
and to explore the association of age, comorbid illnesses
and hospital or extended care facility stay with C.
glabrata colonisation of the oral cavity.
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Methods
Patients and setting
Three populations of adults were studied from June
2006 to April 2008. The first group included healthy
adults living in the community. The second group
comprised adults who were hospitalised for at least
3 days in either medical or surgical units at the
Veterans Affairs Ann Arbor Healthcare System or the
St. Joseph Mercy Health System, Ann Arbor, Michigan.
The third group comprised residents of extended care
facilities in southeastern Michigan and included those in
community nursing homes, the extended care unit at
the Veterans Affairs Hospital and the long-term acute
care unit at St. Joseph Mercy Health System. An attempt
was made to enrol similar numbers of subjects of four
age ranges, 18–39, 40–59, 60–79 and ‡80 years of
age, in each of the above three categories.
This project was approved by the Institutional Review
Boards of the University of Michigan, the Veterans
Affairs Healthcare System and the St. Joseph Mercy
Health System. Written informed consent was obtained
from all subjects. If a subject in an extended care facility
was unable to provide informed consent because of
cognitive difficulties, written informed consent was
obtained from their durable power of attorney.
Baseline demographic data and information related to
risk factors were recorded. Information of interest
included underlying medical conditions, denture use,
prior surgical and dental procedures, and receiving
immunosuppressive therapy, antibacterial agents and
psychotropic drugs. Patients who had a diagnosis of
thrush or who had received antifungal agents during
the prior 30 days were excluded.
Microbiological methods
Samples were obtained from the buccal mucosa,
posterior pharynx, palate, dorsal surface of the tongue
and if applicable, upper dentures using individual sterile
rayon-tipped applicator sticks. It was felt to be too
difficult for some patients and too risky for others to do
an oral rinse to obtain material for culture. Samples
were streaked using a four-quadrant method onto BBL
CHROMagar Candida (BD Diagnostics, Baltimore, MD,
USA). Plates were incubated at 35 C for 72 h. All
phenotypically different cream, pink, purple or blue
colonies were isolated for further study, and identifica-
tion of C. glabrata was verified by the API 20C System
(Bio-Merieux Vitek, Hazelwood, MO, USA). All pheno-
typically different green colonies were identified as
Candida albicans. The identification of other species by
other colours was established by the API 20C System.
The amount of growth on each plate was quantified as
1+ (<10 total colonies), 2+ (10–100 total colonies) and
3+ (>100 colonies). Colonisation was defined as at least
one oral cavity site positive for Candida species.
Data analysis
Univariate analysis using simple logistic regression
identified risk factors for yeast colonisation among
study patients. A two-tailed P-value of 0.05 or less
was considered statistically significant. Crude odds
ratios (OR) and 95% confidence intervals (CI) were
calculated. Age was represented in a continuous fashion
in our model with 1 year serving as the unit of measure.
Variables that were significant at a P-value of 0.20 by
univariate analysis, as well as those variables that had
a priori clinical significance, were analysed using mul-
tivariable logistic regression modelling. All statistical
analyses were performed using SAS 9.1 (SAS Institute
Inc, Cary, NC, USA).
Results
The number of persons enrolled was 408, which
included 136 (33.3%) who lived in the community,
126 (30.9%) who were residents of extended care
facilities and 146 (35.8%) who were hospitalised. Of
the 408 subjects, 70 (17.1%) were aged 18–39 years,
113 (27.7%) were aged 40–59 years, 149 (36.6%) were
aged 60–79 years and 76 (18.6%) were aged >80 years.
A history of denture use was obtained in 124 persons,
102 (82.2%) of whom were >60 years old.
Yeast colonisation
Oropharyngeal colonisation with any yeast species was
found in 219 subjects (53.7%). Colonisation was much
less common in those <40 years of age when compared
with the older age groups. Only 15 (21.4%) subjects
aged 18–39 years were colonised with any yeast species
at any site, whereas 54.9% of those between the ages 40
and 59 years, 63.1% of those aged 60–79 years and
63.2% of those aged older than 80 years were colon-
ised, OR, 1.03 (95% CI, 1.02–1.04) (Table 1). The OR of
1.03 suggests that for every decade, the odds of having
yeast colonisation increases by 30%. We did not observe
a difference in colonisation rates by gender (P = 0.52).
Of the 219 persons colonised, 43 (19.6%) were from the
community, 87 (39.7%) from extended care facilities
and 89 (40.6%) from hospitals. When compared with
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patients from extended care facilities and hospitals,
subjects from the community had only 25% as much
risk of colonisation [OR: 0.25 (CI: 0.16–0.39),
P < 0.001].
Yeast colonisation was associated with many factors
by univariate analysis (Table 1). A strong association
was found with dentures. A total of 124 patients wore
dentures; in 99 patients, these were upper dentures. By
multivariate analysis, the independent factors associ-
ated with colonisation were age, denture use and receipt
of psychotropic agents (Table 2).
The most common colonising species was C. albicans,
found in 192 (88%) subjects, followed by C. glabrata in
62 (28%) and Candida tropicalis in 11 (5%) subjects.
Other species including Candida parapsilosis, Candida
famata, Candida lusitaniae and Saccharomyces cerevisiae
were uncommonly found. A total of 55 (25.1%) persons
were colonised with two species, and 44 of these 55
were colonised with C. glabrata and C. albicans. Among
denture wearers, C. albicans was the most common
species isolated, followed by C. glabrata. Of the 99 upper
dentures, 84 were available for cultures to be taken and
59 (70.2%) samples resulted in the growth of yeast. Of
the other sites, 187 ⁄ 407 (45.9%) of the dorsal tongue
samples, 172 ⁄ 406 (42.4%) of oropharyngeal samples,
160 ⁄ 408 (39.2%) of buccal samples and 147 ⁄ 397
(37%) of palate samples resulted in the growth of yeast
(Fig. 1).
Candida glabrata colonisation
Colonisation with C. glabrata was found in 62 subjects
(15.2%), including 15 (13.2%) of those aged 40–
59 years, 31 (20.8%) of those aged 60–79 years and
Table 1 Characteristics of subjects with
colonisation with any yeast compared




with yeast OR (95% CI)1 P-value
Number 219 189
Age2 65.8 ± 16.1 54.7 ± 21.9 1.03 (1.02–1.04) <0.001
Location
Community 43 (19.6) 93 (49.2) 0.25 (0.16–0.39) <0.001
Extended care 87 (39.7) 39 (20.6)
Hospital 89 (40.6) 57 (30.2)
Males 141 (64.3) 118 (62.4) 1.1 (0.7–1.6) 0.68
Diabetes 69 (31.5) 39 (20.6) 1.8 (1.1–2.8) 0.01
Radiation therapy 4 (2) 5 (3) 0.7 (0.2–2.6) 0.57
Head ⁄ neck cancer 4 (2) 5 (3) 0.7 (0.2–2.6) 0.57
COPD 56 (25.6) 20 (10.6) 2.9 (1.7–5.1) <0.001
Asthma 21 (9.6) 25 (13.2) 0.7 (0.4–1.3) 0.25
Dry mouth 72 (32.9) 28 (14.9) 2.8 (1.7–4.6) <0.001
Cirrhosis 9 (4.1) 3 (1.6) 2.7 (0.7–10) 0.13
Dentures 96 (43.8) 28 (14.8) 4.9 (2.7–7.2) <0.001
Periodontal disease 45 (20.6) 22 (11.7) 2.0 (1.1–3.4) 0.02
Steroid inhaler 34 (15.5) 14 (7.4) 2.3 (1.2–4.4) 0.01
Immunosuppressives 41 (18.7) 14 (7.4) 2.9 (1.5–5.4) <0.001
Psychotropic agents 102 (46.6) 48 (25.4) 2.5 (1.7–3.9) <0.001
Antibiotics 117 (53.4.6) 60 (31.8) 2.4 (1.6–3.7) <0.001
Recent hospitalisation3 82 (37.4) 43 (22.8) 2.0 (1.3–3.1) 0.001
COPD, chronic obstructive pulmonary disease.
1Odds ratio and 95% confidence interval.
2OR for age reported for 1-year unit.
3Hospitalisation within the previous 30 days.
Table 2 Multivariate analysis of select patient characteristics
associated with colonisation by any yeast.
Unadjusted Adjusted
P-valueOR (95% CI)1 OR (95% CI)1
Age2 1.03 (1.02–1.04) 1.02 (1.0–1.05) 0.01
Dentures 4.9 (2.7–7.2) 3.5 (2.1–6.1) <0.001
Psychotropic agents 2.5 (1.7–3.9) 1.8 (1.1–2.9) 0.02
Presence of dry mouth 2.8 (1.7–4.6) 1.6 (0.9–2.7) 0.11
Receipt of antibiotics 2.4 (1.6–3.7) 1.6 (0.9–2.6) 0.08
Recent hospitalisation3 2.0 (1.3–3.1) 1.5 (0.9–2.6) 0.10
1Odds ratios and 95% confidence intervals based on a multivari-
able logistic regression adjusting for age, dentures, use of psycho-
tropic agents, presence of dry mouth, receipt of antibiotics and
recent hospitalisation.
2OR for age reported for 1-year unit.
3Hospitalisation within the previous 30 days.
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16 (21.1%) of those aged ‡80 years of age (Fig. 2). No
person <40 years of age was colonised with C. glabrata.
Only 9 ⁄ 136 (6.6%) of persons from the community, all
of whom were >60 years of age, were colonised with C.
glabrata, compared with 28 ⁄ 126 (22.2%) residents of
extended care facilities and 25 ⁄ 146 (17.1%) hospita-
lised patients. Of the nine persons who lived in the
community and who had C. glabrata colonisation, eight
wore dentures. The mean age of persons colonised with
C. glabrata was 71.5 ± 12.4 years, compared with those
not colonised with C. glabrata, 58.7 ± 20.2 years
(P < 0.001) and those not colonised with any yeast,
54.6 ± 21.9 years (P < 0.001). Colonisation with C.
glabrata varied among different sites in the oral cavity,
but generally was similar to that noted for any yeast;
33.3% of dentures yielded C. glabrata when sampled
(Fig. 1). The amount of growth of C. glabrata varied
among different locations in the mouth and in different
age groups. Dentures were the site most heavily
colonised, and subjects >60 years of age had heavier
growth of yeast from all sites compared with younger
subjects (data not shown).
Univariate analysis of risk factors showed that age,
diabetes mellitus, denture use and use of psychotropic
agents were associated with colonisation with C. glab-
rata, and living in the community was protective
against colonisation (Table 3). Multivariate analysis
showed that increasing age, dentures and use of
psychotropic medications were independently associ-
ated with C. glabrata colonisation, and community
dwelling was strongly protective (Table 4).
Discussion
Colonisation of the oral cavity with Candida species has
been studied in different patient populations, including
patients with HIV infection,11,12 those with diabetes,13
neonates, children, older adults8,9,14,15 and residents of
extended care facilities.10,16,17 In all these studies, C.
albicans has been the yeast most commonly isolated
from the oral cavity. Few studies have focused on
colonisation of the oral cavity with C. glabrata.
We found that C. glabrata colonisation of the oral
cavity increased with age, and this increase appeared to
be independent of denture use. The effect of increasing
age on C. glabrata colonisation was previously noted in
a study on 93 community-dwelling older adults, aged
60 to >80 years.8 In that study, comparison with a
younger age group was not performed. The results
differed from the present study in that C. glabrata was
found only in those >70 years of age, and among
persons without dentures, C. glabrata was found only in
those >80 years of age.8 Another study of oral yeast
colonisation that compared 239 healthy subjects in
China with 483 healthy subjects in North America
between the ages of 15 and 76 years, found only one
isolate of C. glabrata in each population group.16
However, the samples were taken from the gingival
mucosa, which may not reflect the areas more likely to
demonstrate colonisation by C. glabrata.
One could argue that our findings may have differed
if we had used oral rinses rather than swabbing to
isolate yeast from the oral cavity. It is possible that
we missed low-level colonisation with yeast by using
swabs instead of rinses. However, we wished to identify
colonisation at different sites within the oral cavity and
that is not feasible with the oral rinse technique. In
addition, it is difficult for hospitalised patients and some
nursing home patients to carry out the rinse proce-
dure, and this could have led to unintended differences
among the groups and thus skewed the results.
In addition to older age, psychotropic drugs and
dentures emerged as important risk factors for C. glabrata


















Palate Buccal Oropharynx Tongue Dentures
Site
Figure 1 Oral cavity colonisation with any yeast and with Candida
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Figure 2 Oral cavity colonisation with Candida glabrata in relation
to age.
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certain psychotropic drugs and may predispose to oral
candidiasis.18,19 Low salivary flow rates were noted to
be inversely related to the intensity of saliva carriage
with C. albicans and C. parapsilosis, but were not studied
in relation to C. glabrata.19 However, we found no
significant association with xerostomia although our
definition was based on the patients perception of
whether they had dry mouth and not on an objective
measurement of salivary flow.
Denture use is known to be a risk factor for oral cavity
yeast colonisation20–22 and also has been linked to
C. glabrata oral colonisation in one study.8 In our study,
denture wearers were three times more likely to harbour
C. glabrata than those who wore no dentures, and this
emerged as the strongest risk factor for colonisation.
Most experimental work on the adherence of Candida
to denture materials has used C. albicans as the test
organism because it is the predominant yeast found
colonising dentures. Only a few studies have been
performed with C. glabrata. These have shown that this
species can adhere to both cold-cured and heat-cured
acrylic resins that are commonly used to manufacture
dentures and that adherence to dental acrylic of many,
but not all, C. glabrata strains was greater than that of
C. albicans strains.23,24
An important finding from our study was that
C. glabrata colonisation was uncommon in commu-
nity-dwelling persons, regardless of age, but was much
more common in those in hospital or residing in an
extended care facility. There was no difference of the
rates of colonisation between persons in hospital and
those in an extended care facility. There were no
community-dwelling subjects <60 years of age who had
C. glabrata colonisation. This raises the question of
whether C. glabrata is acquired in the hospital or
extended care setting or is perhaps selected for in those
settings. We did not find C. glabrata to be a major
Table 3 Characteristics of subjects with
Candida glabrata colonisation compared





C. glabrata OR (95% CI)1 P-value
Number 62 346
Age2 71.5 ± 12.4 58.7 ± 20.2 1.04 (1.02–1.06) <0.001
Location
Community 9 (14.5) 127 (36.7) 0.29 (0.14–0.61) <0.001
Extended care 28 (45.2) 98 (28.3)
Hospital 25 (40.3) 121 (35)
Males 35 (56) 224 (65) 0.8 (0.4–1.3) 0.36
Diabetes 24 (38.7) 84 (24.3) 2.0 (1.1–3.5) 0.02
Radiation therapy 2 (3.2) 7 (2) 1.6 (0.3–8) 0.63
Head ⁄ neck cancer 2 (3.2) 7 (2) 1.6 (0.3–8) 0.63
COPD 15 (24.2) 61 (17.6) 1.5 (0.8–2.8) 0.22
Asthma 7 (11.3) 39 (11.3) 1.0 (0.4–2.4) 1.0
Dry mouth 21 (34) 79 (23) 1.7 (0.96–3.1) 0.06
Cirrhosis 4 (6.5) 8 (2.3) 2.9 (0.85–10) 0.09
Dentures 45 (72.6) 79 (22.8) 8.9 (4.9–16.5) <0.001
Periodontal disease 15 (24.2) 52 (15) 1.8 (0.94–3.5) 0.07
Steroid inhaler 10 (16.1) 38 (11) 1.6 (0.73–3.3) 0.25
Immunosuppressives 11 (17.7) 44 (12.8) 1.5 (0.7–3) 0.29
Psychotropic agents 33 (53.2) 117 (33.8) 2.2 (1.3–3.8) 0.004
Antibiotics 32 (51.6) 145 (41.9) 1.5 (0.9–2.5) 0.16
Recent hospitalisation3 23 (37.1) 102 (29.5) 1.4 (0.8–2.5) 0.23
COPD, chronic obstructive pulmonary disease.
1Odds ratio and 95% confidence interval.
2OR for age reported for 1-year unit.
3Hospitalisation within the previous 30 days.
Table 4 Multivariate analysis of select patient characteristics
associated with Candida glabrata colonisation.
Unadjusted Adjusted
P-valueOR (95% CI)1 OR (95% CI)1
Age2 1.04 (1.02–1.06) 1.01 (1.001–1.03) 0.03
Diabetes 2.0 (1.1–3.5) 1.1 (0.65–1.8) 0.76
Dentures 8.9 (4.9–16.5) 3.1 (1.8–5.3) <0.001
Psychotropic agents 2.2 (1.3–3.8) 1.7 (1.01–2.7) 0.05
Community dwelling 0.29 (0.14–0.61) 0.45 (0.26–0.77) 0.004
1Odds ratios and 95% confidence intervals based on a multivari-
able logistic regression adjusting for age, diabetes, dentures, use
of psychotropic agents and patient location (community dwelling
or not).
2OR for age reported for 1-year unit.
Candida glabrata colonisation
 2010 Blackwell Verlag GmbH • Mycoses 54, 531–537 535
coloniser of hands of health care workers in a prospec-
tive study in an intensive care unit, nor did we find
evidence of transmission to patients in this setting.25
Others have described nosocomial spread of C. glabrata
and have found this species contaminating environ-
mental surfaces, but not the hands of health care
workers.26
The results from this study should not be interpreted
as providing evidence that another agent, other than
fluconazole, should be used to treat thrush or denture
stomatitis in older adults. The subjects in this study did
not have thrush and were asymptomatically colonised
with yeast. This study was not aimed at addressing the
issue of defining the aetiological agent causing thrush in
these different populations.
Whether increased oral colonisation with C. glabrata
in older adults, especially those in hospital and extended
care settings, has relevance to the increase in blood-
stream infections caused by this organism in older
adults is not addressed in this study. It is highly unlikely
that the oral cavity is a site from which dissemination
occurs. Dissemination more likely originates from the
bowel, and assessment of growth in stool or rectal
colonisation with C. glabrata would be more directly
relevant to this question. Unfortunately, it is difficult to
enlist community-dwelling individuals to undergo
swabbing of the rectum or provide a stool specimen,
and we thought it was important in this study to
compare community-dwelling persons with those in
hospital and extended care facilities. Indirect evidence
was obtained in our prior study in the intensive care
setting, in which both oral and rectal colonisation was
assessed. Most patients were found to have the same
yeast species at both locations, and C. glabrata was the
most common coloniser of the rectum in patients in
the surgical intensive care unit.25 Only when studies
are performed that correlate specific strains causing
fungaemia with those colonising various body sites,
including the oral cavity, will the role of increased
colonisation with C. glabrata with increasing age, be
better defined.
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